search icon
search icon
Flag Arrow Down
Română
Română
Magyar
Magyar
English
English
Français
Français
Deutsch
Deutsch
Italiano
Italiano
Español
Español
Русский
Русский
日本語
日本語
中国人
中国人

Change Language

arrow down
  • Română
    Română
  • Magyar
    Magyar
  • English
    English
  • Français
    Français
  • Deutsch
    Deutsch
  • Italiano
    Italiano
  • Español
    Español
  • Русский
    Русский
  • 日本語
    日本語
  • 中国人
    中国人
Sections
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
About Us
Contact
Privacy policy
Terms and conditions
Quickly scroll through news digests and see how they are covered in different publications!
  • News
  • Exclusive
    • INSCOP Surveys
    • Podcast
    • EU
    • Diaspora
    • Republic of Moldova
    • Politics
    • Economy
    • Current Affairs
    • International
    • Sport
    • Health
    • Education
    • IT&C knowledge
    • Arts & Lifestyle
    • Opinions
    • Elections 2025
    • Environment
134 new news items in the last 24 hours
  1. Home
  2. International

The Swiss pharmaceutical company Novartis announced on Sunday the signing of an agreement to acquire the American biotechnology firm Avidity Biosciences for approximately 12 billion dollars.

Adrian Rusu
whatsapp
facebook
linkedin
x
copy-link copy-link
27 October 2025, 06:54
main event image
International
Foto: shutterstock.com/ro
google-preference

Always see our news on Google

Novartis, the Swiss pharmaceutical giant, announced on Sunday that it has agreed to acquire Avidity Biosciences, a biopharmaceutical company based in San Diego, valued at 12 billion dollars. This acquisition will create a portfolio of leading products in the field of spinal muscular atrophy and genetic neuromuscular diseases. The transaction is expected to be finalized in the first half of 2026, after Avidity's precision cardiology programs are spun off into a new company.

Novartis CEO, Vas Narasimhan, emphasized the company's commitment to delivering innovative and life-changing medicines. In the context of pressures from the Trump administration to move production to the U.S., Novartis previously announced a 23 billion dollar investment in the United States over the next five years.

Sources

sursa imagine
France24
Novartis acquiring US firm Avidity Biosciences for $12 bn
sursa imagine
Stiripesurse
Compania farmaceutică elveţiană Novartis achiziţionează Avidity Biosciences. Suma fabuloasă a tranzacției
sursa imagine
News.ro
Novartis achiziţionează Avidity Biosciences, pentru aproximativ 12 miliarde de dolari

Latest News

23:17

ECB reorganizes its leadership in 2027 / Spain is expected to take over the institution’s presidency, while France and Germany propose candidates for key positions

22:59

Ilie Bolojan criticizes the administrative reorganization of the Government formed mostly of PSD members: “There is nothing serious”

22:43

A delivery driver from Sri Lanka attacked in Iași County. The attacker destroyed his scooter and phone

22:27

Ilie Bolojan, on the risk of the PNL splitting: “We do not expect anyone to leave the party”

22:04

Donald Trump announces good talks with Vladimir Putin and says that the Russian leader wants to end the war in Ukraine through diplomatic means

See more news

NEWS ON THE SAME TOPICS

event image
IT&C knowledge
Novo collaborates with Anthropic to use artificial intelligence in the research and development of new medicines
event image
International
Paramount Skydance has completed its acquisition of Warner Bros. Discovery in a $110 billion transaction
event image
IT&C knowledge
Nvidia will acquire the Hugging Face artificial intelligence platform for nearly 13 billion dollars
event image
Economy
Nvidia buys back $150 billion worth of shares
event image
International
Germany will provide €400 million to maintain Sanofi’s insulin production and reduce the risk of shortages in Europe
event image
Economy
Nvidia reported a net profit more than double compared to last year. Revenues exceeded analysts' forecasts.
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview app preview
Novartis Avidity Biosciences agreement retrieve

Editor’s Recommendations

main event image
Current Affairs
2 hours ago

EUROCONTROL blocks the sums owed to ROMATSA again / The garnishment was imposed at Pfizer’s request in the dispute concerning COVID-19 vaccines

Sources
imagine sursa
imagine sursa
imagine sursa
imagine sursa
main event image
Exclusive
12 hours ago

EXCLUSIVE | Romania, as viewed by the Russian press / The scenario of unification with the Republic of Moldova, described as a “capitulation” of Chișinău

main event image
Opinions
7 hours ago

Andrei Cornea: Politics, Ethics and Fanaticism

app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview
app store badge google play badge
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
  • About Us
  • Contact
Privacy policy
Cookies Policy
Terms and conditions
Open source licenses
All rights reserved Strategic Media Team SRL

Technology in partnership with

anpc-sal anpc-sol